Project Grant R01NS147032
- Federal Grant Award Summary Duke University's Office of Research Administration received a $1,042,170 project grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective September 1, 2025, with completion targeted for August 31, 2033. The award supports computational modeling research designed to advance understanding of intracranial brain stimulation and...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $107,984 Project Grant award effective August 1, 2025, through July 31, 2027, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The award funds basic neuroscience research investigating three-factor learning rules at cortico-basal ganglia synapses that drive motor skill...
- Federal Project Grant Award Summary Duke University received a $298,805 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through April 30, 2030. The award supports investigator-initiated research focused on elucidating the role of cell-type-specific inhibitory and disinhibitory circuits within the cerebellum during motor...
- Federal Grant Award Summary Duke University received a $195,889 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on June 16, 2025. The research investigates human-specific splicing regulation in neurogenesis and neurological disease by examining post-transcriptional gene expression mechanisms. The project delivers scientific research products...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Van Andel Research Institute $123,163 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective June 1, 2025, with completion targeted for September 26, 2025. The project focuses on identifying cortical neuronal vulnerability and resilience in Parkinson's disease, specifically investigating which neurons are susceptible to misfolded...
- Federal Project Grant Award Summary Rockefeller University received a $220,260 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025 through July 31, 2030. The grant supports a five-year basic research investigation into RNA regulation mechanisms in medium spiny neurons of the striatum as they relate to Parkinson's Disease...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $227,205 Project Grant award dated May 9, 2025, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research project, which extends through April 30, 2030, examines the effects of the Parkinson's Disease-associated protein LRRK2 (leucine-rich repeat kinase 2) on lysosomal...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $414,953 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through April 30, 2030. This award supports investigator-initiated research exploring inflammasomes as drivers of sexual dimorphism in glioma therapeutic...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $1.2M project grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded March 13, 2025, with completion scheduled for January 31, 2030. The award funds research investigating the pathogenic mechanisms of inflammatory subventricular zone (SVZ) injury in preterm...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $422,125 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 15, 2025, with completion scheduled for July 31, 2027. This award funds research investigating the role of the DNAJC12 protein in dopamine biosynthesis and...
Federal Grant Award Summary Duke University's Office of Research Administration received a $619,580 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective April 1, 2026 through March 31, 2031. The award funds comprehensive research investigating neuronal kinase signaling mechanisms in health and disease, with particular emphasis on Parkinson's disease and disease-associated mutations such as LRRK2G2019S. The research integrates artificial intelligence and machine learning algorithms with advanced CRISPR-based proteomics and in vivo models to elucidate how kinases dynamically regulate proteomes in dopamine neurons and how disease-associated mutations alter kinase-substrate interactions and allostery. The deliverables from this five-year investigation are expected to advance fundamental understanding of kinase neurobiology, clarify molecular mechanisms underlying neurological disease pathogenesis, and generate validated computational frameworks and experimental findings that inform future therapeutic strategies targeting dysregulated kinase signaling. Outcomes will include peer-reviewed research publications, predictive computational models, proteomic datasets, and experimental validation supporting the development of kinase-directed interventions for neurodegenerative disorders. This research addresses core NINDS objectives to support basic and translational investigations that expand knowledge of nervous system function and reduce the burden of neurological disease.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $619.6k | 2/18/26 |